July 10, 2020 / Karen Robinson-Jacobs, Forbes Staff TOPLINE A German biotech firm working with New York-based pharma giant Pfizer Inc. to develop a coronavirus vaccine claims it’s confident it will be ready to seek regulatory approval for widespread distribution of its drug by the end of the year, its chief executive told the Wall Street …